· The clinical study shows that non-invasive vagus nerve stimulation (nVNS) with gammaCore reduces the number of monthly headache days for patients with menstrual related migraine by more than a third
· The second study confirms that nVNS is effective in activating afferent (towards the brain) fibers in the vagus nerve in humans.
A study published in the Journal of Headache and Pain, carried out by Dr. Thomas Kinfe of the University of Bonn, found that twice daily stimulation of the vagus nerve with the hand-held gammaCore nVNS device reduced the number of headache days per monthRead More
Recent release "Brain Beat: Scientific Foundations and Evolutionary Perspectives of Brain Health" from Page Publishing author Michael Hoffmann MD, PhD, is a scientific and philosophical work aiming to educate the reader on the brain's functions.Read More
World Parkinson's Program announces the continuation of its' "Fall Prevention Campaign" by delivering educational material to Africa Parkinson's Association. The material will aid those who suffer from Parkinson's disease and would not be able to afford healthcare supplies otherwise.
BIORAY and BIORAY Kids announces founder and CEO, Stephanie Ray to share new data and information among parents, medical professionals and caregivers at 2nd Annual Autism Education Summit in Dallas. This presentation entitled "Enhancing Heavy Metal and Chemical Detoxification." is scheduled Saturday, September 26 at 4:15pm at the InterContinental Hotel and is open to all attendees.Read More
September is Orthostatic Tremor Awareness Month. Orthostatic Tremor (OT) is an extremely rare, misdiagnosed and undiagnosed disorder affecting adults in midlife, worldwide, in a very life-limiting way. People with OT are unable to stand, but are able to walk. For more information go to orthostatictremor.org.Read More
The Ryan's Quest Foundation, a non-profit organization specific to Duchenne muscular dystrophy, announced today the award of their most recent contribution toward the fight to end Duchenne muscular dystrophy. The Foundation has awarded ReveraGen BioPharma $50,000 towards a clinical trial for a potential steroid alternative.Read More
Neuroscience R&D Technologies Conference to be held in Barcelona, Spain on 3 - 4 December 2015 will gather global neuroscience experts to discuss developments in brain imaging, animal models, neurogames, neuroinformatics and neuromodulation among others.Read More